Nulab Balans Gezondheid
Financiële gezondheid criteriumcontroles 4/6
Nulab has a total shareholder equity of ¥1.5B and total debt of ¥4.0M, which brings its debt-to-equity ratio to 0.3%. Its total assets and total liabilities are ¥3.6B and ¥2.1B respectively.
Belangrijke informatie
0.3%
Verhouding schuld/eigen vermogen
JP¥4.00m
Schuld
| Rente dekkingsratio | n/a |
| Contant | JP¥2.74b |
| Aandelen | JP¥1.49b |
| Totaal verplichtingen | JP¥2.14b |
| Totaal activa | JP¥3.64b |
Recente financiële gezondheidsupdates
Geen updates
Recent updates
Subdued Growth No Barrier To Nulab Inc.'s (TSE:5033) Price
Aug 02
Nulab Inc. (TSE:5033) Shares May Have Slumped 30% But Getting In Cheap Is Still Unlikely
Apr 12Does Nulab (TSE:5033) Deserve A Spot On Your Watchlist?
Apr 05Optimistic Investors Push Nulab Inc. (TSE:5033) Shares Up 54% But Growth Is Lacking
Feb 27Analyse van de financiële positie
Kortlopende schulden: 5033's short term assets (¥3.2B) exceed its short term liabilities (¥2.1B).
Langlopende schulden: 5033's short term assets (¥3.2B) exceed its long term liabilities (¥10.0M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 5033 has more cash than its total debt.
Schuld verminderen: Insufficient data to determine if 5033's debt to equity ratio has reduced over the past 5 years.
Schuldendekking: 5033's debt is well covered by operating cash flow (20275%).
Rentedekking: Insufficient data to determine if 5033's interest payments on its debt are well covered by EBIT.